Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
Journal of Medicinal Chemistry|May 25, 2012
Factors influencing the specificity of inhibitor binding to the human and malaria parasite dihydroorotate dehydrogenasesPaul T P Bedingfield, Deborah Cowen, Paul Acklam, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Macrocyclic inhibitors of the bacterial cell wall biosynthesis enzyme MurDJames R Horton, Julieanne M Bostock, Ian Chopra, et al.Journal of the American Chemical Society|August 9, 2003
pH as a trigger of peptide beta-sheet self-assembly and reversible switching between nematic and isotropic phasesAmalia Aggeli, Mark Bell, Lisa M Carrick, et al.Bioorganic & Medicinal Chemistry Letters|February 7, 2009
Design and synthesis of new hydroxyethylamines as inhibitors of D-alanyl-D-lactate ligase (VanA) and D-alanyl-D-alanine ligase (DdlB)Matej Sova, Gasper Cadez, Samo Turk, et al.Journal of Medicinal Chemistry|November 15, 2021
From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 InhibitorLewis D Turner, Chi H Trinh, Ryan A Hubball, et al.Journal of Medicinal Chemistry|January 19, 2007
Design and synthesis of potent inhibitors of the malaria parasite dihydroorotate dehydrogenaseTimo Heikkilä, Christopher Ramsey, Matthew Davies, et al.Bioorganic & Medicinal Chemistry Letters|July 4, 2017
Interconvertible geometric isomers of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors exhibit multiple binding modesGlenn A McConkey, Paul T P Bedingfield, David R Burrell, et al.Chemmedchem|April 5, 2012
Identification of selective inhibitors of the potassium channel Kv1.1-1.2((3)) by high-throughput virtual screening and automated patch clampSören J Wacker, Wiktor Jurkowski, Katie J Simmons, et al.The Journal of General Virology|December 19, 2025
Identification and characterization of candidate inhibitors of the SARS-CoV-2 nsp14 3'-5' exoribonucleaseVictoria Easton, Martin J McPhillie, Igor Andrade Santos, et al.Iucrj|May 17, 2018
X-ray and cryo-EM structures of inhibitor-bound cytochrome <i>bc</i><sub>1</sub> complexes for structure-based drug discoveryKangsa Amporndanai, Rachel M Johnson, Paul M O'Neill, et al.Pageof 8